Measures involving glucose tolerance                


Select table page: First Prev 1 - 10 / 42 (42) Next Last
    Access protocols via the Procedure column.
Sort/
Pick
Data set
Procedure / Protocol
Treatment
Phenotype Measure / Variable (click to view)
Panel
No. of Strains
Sex
Age
Sample Size (Avg)
Year
    Attie2 glucose tolerance high-fat high-sucrose diet glucose level at t=0 after ~14 wks on diet (4h fast)   [mg/dL]  GLU_0min   110706     DO population both 18wks N=248 2018
    Attie2 glucose tolerance high-fat high-sucrose diet insulin level at t=0 after ~14 wks on diet (4h fast)   [ng/mL]  INS_0min   110707     DO population both 18wks N=248 2018
    Attie2 glucose tolerance high-fat high-sucrose diet HOMA-IR: (glucose x insulin) / 405 at t=0 after ~14 wks on diet (4h fast)  HOMA_IR   110708     DO population both 18wks N=248 2018
    Attie2 glucose tolerance high-fat high-sucrose diet HOMA-B: (360 x insulin) / (glucose minus 63) at t=0 after ~14 wks on diet (4h fast)  HOMA_B   110709     DO population both 18wks N=246 2018
    Attie2 glucose tolerance high-fat high-sucrose diet glucose area under curve (AUC) after ~14 wks on diet without correction for baseline difference (4h fast)   [AUC]  GLU_AUC_tot   110710     DO population both 18wks N=248 2018
    Attie2 glucose tolerance high-fat high-sucrose diet glucose area under curve (AUC) after ~14 wks on diet after subtraction of glucose at t=0 (4h fast)   [AUC]  GLU_AUC_adj   110711     DO population both 18wks N=248 2018
    Attie2 glucose tolerance high-fat high-sucrose diet insulin area under curve (AUC) after ~14 wks on diet without correction for baseline difference (4h fast)   [AUC]  INS_AUC_tot   110712     DO population both 18wks N=248 2018
    Attie2 glucose tolerance high-fat high-sucrose diet insulin area under curve (AUC) after ~14 wks on diet after subtraction of insulin at t=0 (4h fast)   [AUC]  INS_AUC_adj   110713     DO population both 18wks N=248 2018
    Auwerx1 glucose tolerance high-fat diet glucose baseline, glucose tolerance test (pregavage, overnight fast)   [mg/dL]  ogtt_gluc_t0   111244     CD    HFD BXD w/par 57 m 17wks N=4 2016
    Auwerx1 glucose tolerance high-fat diet glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min   [mg/dL]  ogtt_gluc_t15   111246     CD    HFD BXD w/par 57 m 17wks N=4 2016
    All boxes             To see more rows use the paging control at top.


  •   Or, add these measures to your collection.
       
  •     no folder
  •     put them in new folder  





Other available data sets:
Data set Procedure What's in this data set Panel Sex Age (weeks) Year
ITP1 glucose tolerance
with (R/S)-1,3-butanediol, 17-a-estradiol, 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride, 2-(2-Hydroxyphenyl)benzoxazole, 3-(3-hydroxybenzyl)-5-methylbenzo[d]oxazol-2(3H)-one, 4-OH-a-phenyl-N-tert-butyl nitrone, 4-phenylbutyrate, acarbose, aspirin, astaxanthin, b-guanidinopropionic acid, caffeic acid phenethyl ester, canagliflozin, captopril, candesartan cilexetil, curcumin, dimethyl fumarate, enalapril, fisetin, fish oil, geranylgeranyl acetone, glycine, green tea extract, INT-767 FXR/TGR5 agonist, inulin, L-Leucine, meclizine, medium-chain triglyceride, metformin, metformin plus rapamycin, methylene blue, minocycline, MitoQ, mycophenolic acid, nicotinamide riboside, nitroflurbiprofen, nordihydroguaiaretic acid, oxaloacetic acid, PB125, protandim, rapamycin, rapamycin plus acarbose, resveratrol, SG1002, simvastatin, sulindac, syringaresinol, TM5441, ursodeoxycholic acid, ursolic acid, 16-a-hydroxyestriol, 2,4-dinitrophenol, a-Ketoglutarate, Hydralazine, Nebivolol, Sodium thiosulfate 		Postprandial glucose. Invervention vs. controls. UM-HET3 population both various 2004-2024